EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Global, Regional and National Burden and Temporal Trends of Gastroesophageal Reflux Disease, 1990 to 2021 and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021

Claire Chenwen Zhong, junjie huang

Digestive Diseases · 2026-11-06

DOI: 10.1159/ddi/acnag016 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background: Gastroesophageal reflux disease (GERD) is a prevalent condition characterized by reflux esophagitis, Barrett’s esophagus, and symptoms such as retrosternal burning and regurgitation. This study aims to assess the global burden of GERD from 1990 to 2021 and project trends until 2050. Methods: This study utilized data from the Global Burden of Disease (GBD) 2021 database to estimate GERD incidence, and disability-adjusted life years (DALYs) from 1990 to 2021, with projections to 2050. Age-standardized rates (ASRs) were calculated per 100,000 persons with 95% uncertainty intervals (UIs). This study presented the GBD estimates along with 95% uncertainty intervals (UIs) which were values at the 12.5th and 487.5th ordered draws from the 500 iterations. Results: In 2021, GERD accounted for 324 million incident cases and 6.3 million DALYs globally. The age-standardized incidence rate (ASIR) was 3,880 per 100,000 person-years, while the DALY rate was 75.6 per 100,000. South Asia had the highest absolute burden (96.5 million cases), whereas Latin America and the Caribbean reported the highest ASIR (6,180 per 100,000). India had the greatest number of cases (76.3 million) and DALYs (1.49 million), while Brazil had the highest ASIR (6,250 per 100,000). Females had a higher burden than males, with ASIRs of 4,030 vs. 3,740 per 100,000. Low-middle SDI regions had the highest ASIR (4,890 per 100,000) and DALY rate (96.1 per 100,000). Between 1990 and 2021, GERD cases and DALYs increased by 80.1% and 82.5%, respectively, with the largest growth in low SDI regions. Conclusion: GERD poses a growing global health burden with increasing incidence and DALYs. The disease's multifactorial nature complicates prevention, highlighting the need for targeted interventions. Targeted interventions are essential, focusing on modifiable risk factors and promoting community awareness.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →